- Home
- POET vs CBLL Comparison
POET vs CBLL Comparison
Compare POET & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- CBLL
- Stock Information
- Founded
- POET 1972
- CBLL 2014
- Country
- POET Canada
- CBLL United States
- Employees
- POET N/A
- CBLL N/A
- Industry
- POET Semiconductors
- CBLL
- Sector
- POET Technology
- CBLL
- Exchange
- POET Nasdaq
- CBLL Nasdaq
- Market Cap
- POET 479.0M
- CBLL 433.7M
- IPO Year
- POET N/A
- CBLL 2024
- Fundamental
- Price
- POET $5.15
- CBLL $11.95
- Analyst Decision
- POET Strong Buy
- CBLL Strong Buy
- Analyst Count
- POET 2
- CBLL 6
- Target Price
- POET $6.25
- CBLL $33.00
- AVG Volume (30 Days)
- POET 1.2M
- CBLL 267.5K
- Earning Date
- POET 11-13-2025
- CBLL 11-11-2025
- Dividend Yield
- POET N/A
- CBLL N/A
- EPS Growth
- POET N/A
- CBLL N/A
- EPS
- POET N/A
- CBLL N/A
- Revenue
- POET $467,946.00
- CBLL $77,419,000.00
- Revenue This Year
- POET $8,377.56
- CBLL $35.45
- Revenue Next Year
- POET $1,061.73
- CBLL $28.18
- P/E Ratio
- POET N/A
- CBLL N/A
- Revenue Growth
- POET 302.50
- CBLL 42.16
- 52 Week Low
- POET $2.98
- CBLL $10.01
- 52 Week High
- POET $7.79
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- POET 44.59
- CBLL 45.64
- Support Level
- POET $5.26
- CBLL $11.30
- Resistance Level
- POET $5.75
- CBLL $12.14
- Average True Range (ATR)
- POET 0.28
- CBLL 0.50
- MACD
- POET 0.01
- CBLL 0.15
- Stochastic Oscillator
- POET 18.24
- CBLL 54.39
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.